Android app on Google Play

ARIAD Pharma (ARIA) Prices 15.3M Offering at $19.60/Share

January 24, 2013 10:11 AM EST Send to a Friend
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) announced the pricing of an underwritten public offering of 15,307,000 shares of its common stock, at a price to the public of $19.60 per share. The offering is expected to close on or about January 29, 2013, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 2,296,050 additional shares of common stock to cover over-allotments, if any.

J.P. Morgan Securities LLC, Cowen and Company, LLC and Jefferies & Company, Inc. are acting as joint book-running managers and underwriters for the offering. BMO Capital Markets, Leerink Swann LLC, RBC Capital Markets, LLC and UBS Investment Bank are acting as co-managers for the offering.




You May Also Be Interested In


Related Categories

Corporate News, Equity Offerings

Related Entities

UBS, JPMorgan, Jefferies & Co, BMO Capital, RBC Capital, Cowen & Co

Add Your Comment